• President, World Glaucoma Association (2016 – 2017)
  
• Chair of Council, World Glaucoma Association (2017 – present)
• Member, Academia Ophthalmologica Internationalis (2016 – present)
• President, Asian Angle Closure Glaucoma Club (2019 – present)
• Member, Glaucoma Research Society (2009 – present)
• Board member, Asia-Pacific Glaucoma Society (2011 – present)
• Asia-Pacific Glaucoma Society Chair and Special Interest Group Chair – Genetics (2022 – present)
• Member of the Editorial Boards of Ophthalmology, Eye, Progress in Retina and Eye Research, and Graefe’s Archive for Clinical and Experimental Ophthalmology as well as 5 other journals
  
  
  

• Best Medicine Scientists in Singapore 2023 by Research.com (2023)
• 100 Most Influential Ophthalmologists for Asia Pacific Eye 100 (2023)
• The World Glaucoma Association Founders Award (2021)
  
• 11th American Glaucoma Society International Scholar Award (2021)
• Singapore Translational Research (STaR) Investigator Award, National Medical Research Council, Singapore (2020)
  
• Fellow, ARVO (FARVO, Gold) (2019)
• College Medal and Lecture, 28th Annual Scientific Congress of the College of Ophthalmologists of Sri Lanka (2019)
• Visionary Award, Eye and Vision Health Award (2018)
• Manuel B. Agulto Award, Philippine Glaucoma Society (2018)
• SingHealth Duke-NUS Kwan Im Thong Hood Cho Temple Professorship in Ophthalmology (2018)
• 33rd Asia Pacific Academy Ophthalmology (APAO) Senior Achievement Award (2018)
• Dr Robert Ritch Award for Excellence & Innovation in Glaucoma, The Glaucoma Foundation, USA (2017)
• Distinguished Visionary Leader Award, SingHealth Excellence Awards (2016) 
• Outstanding Researcher Award, NUS University Awards (2016) 
• Silver Award, ARVO Fellow (2016) 
• Singapore Translational Research (STaR) Investigator Award, National Medical Research Council, Singapore (2014) 
• Senior Achievement Award, American Academy of Ophthalmology (AAO) (2014) 
• Alcon Research Institute Award (2013) 
• De Campo Lecture Award, Asia-Pacific Academy of Ophthalmology (2013)
• Faculty Outstanding Researcher Award, Yong Loo Lin School of Medicine, National University of Singapore (2012)
• Achievement Award, Asia-Pacific Academy of Ophthalmology (APAO) (2010)
• President’s Science Award, A-STAR, Singapore (2009)
• GCEO Excellence Award in Biomedical Research, SingHealth (2009) 
• Biomedical Research Council Clinician Scientist Award (Senior Category), National Medical Research Council (2008)
• Distinguished Achievement Award, American Academy of Ophthalmology (AAO) (2008)
• Nakajima Award and Lecture, Asia-Pacific Academy of Ophthalmology (APAO) (2007)
• Biomedical Research Council Clinician Scientist Investigator Award (Junior Category), National Medical Research Council (2005)
• ARVO / Santen Pharmaceutical Travel Fellowship Award, ARVO (2001) 
• Medical Research Fellowship, National Medical Research Council Singapore Totalisator Board (2000)
• Grace Ballas Travelling Fellowship, National Medical Research Council, Singapore (1997)

• Ophthalmic Genetics
  
• Glaucoma: angle closure glaucoma, glaucoma imaging, clinical trials in glaucoma
  
  

1. Genetics of Exfoliation Syndrome Partnership, Li Z, Wang Z, Lee MC…… Ritch R, Wiggs JL, Pasutto F, Schlötzer-Schrehardt U, Ho YS, Aung T, Tam WL, Khor CC. Association of Rare CYP39A1 Variants With Exfoliation Syndrome Involving the Anterior Chamber of the Eye. JAMA. 2021 Feb 23;325(8):753-764. (IF: 45.54).
   

2. He M, Jiang Y, Huang S, Chang DS, Munoz B, Aung T, Foster PJ, Friedman DS. Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial. Lancet. 2019 Apr 20;393(10181):1609-1618. (IF: 53.254).

3. Genetics of Glaucoma in People of African Descent (GGLAD) Consortium., Hauser MA, Allingham RR, Aung T, Van Der Heide CJ, Taylor KD, Rotter JI, Wang SJ, Bonnemaijer PWM, Williams SE, Abdullahi SM, Abu-Amero KK, Anderson MG, Akafo S, Alhassan MB, Asimadu I, Ayyagari R, Bakayoko S, Nyamsi PB, Bowden DW, Bromley WC, Budenz DL, et al. Association of Genetic Variants With Primary Open-Angle Glaucoma Among Individuals With African Ancestry. (Joint First Author). JAMA. 2019 Nov 5;322(17):1682-1691. (IF: 47.661).

4. Aung T, Ozaki M, Lee MC, Schlötzer-Schrehardt U, ……… Khor CC. Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci. Nature Genetics. 2017 Jul;49(7):993-1004. (IF: 27.959).

5. Aung T, Ozaki M, Mizoguchi T, Allingham RR, …. Khor CC. A common variant mapping to CACNA1A is associated with susceptibility to Exfoliation syndrome. Nature Genetics 2015,Jun,47(6) 689 (IF: 29.352).

6. Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. Lancet. 2017 Nov 11;390(10108):2183-2193. (IF: 47.831).

7. Khor CC, Do T, Jia H, Nakano M, George R, …. Aung T. Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma. Nature Genetics 2016 May;48(5):556-62. (IF: 29.352).

8. Hysi PG, Cheng CY, Springelkamp H, Macgregor S, ………..Aung T. Genome-wide Analysis of Multiethnic Cohorts Identifies Four New Loci Influencing Susceptibility to Increased Intraocular Pressure and Susceptibility to Glaucoma. Nature Genetics- 2014; 46(10): 1126-30. (IF: 35.532).

9. Weinreb RN, Aung T, Medeiros FA. The Pathophysiology and Treatment of Glaucoma: A Review. JAMA. 2014 May 14;311(18):1901-11. (IF: 30.026).

10. Vithana EN, Khor CC,…Aung T. Genome-wide association analyses identify three new susceptibility loci for Primary Angle Closure Glaucoma. Nat Genetics 2012; 44: 1142-6. (IF: 35.532)

Current Research Funding Support

• Large Collaborative Grant (LCG): Tackling and Reducing Glaucoma Blindness with Emerging Technologies (TARGET). (NMRC) Corresponding and Theme PI
• Singapore Angle Closure Glaucoma Program: From Genetics to Precision Medicine and Therapy. (NMRC) PI.
• Retinal Analytics via Machine Learning Aiding Physics (RAMP). (NRF/ MIT Alliance) Lead PI.

Commercial Research Grants

• A phase III, randomized, observer-masked, active-controlled, parallel-group, multinational and multicentre study assessing the safety and efficacy of DE-117 ophthalmic solution 0.002% compared with latanoprost ophthalmic solution 0.005% in subjects with open-angle glaucoma or ocular hypertension- PEONY study (Santen Pharmaceutical Co., Ltd.)